BRCA1 and breast cancer: This 17q25.3 gain was detected in 90% of the BRCA1-mutated BC (86% of the mutated TNBC and 100% of the mutated non-TNBC) in our cohort and was also highly recurrent in the BRCA1-mutated breast cancer of the TCGA cohort.